FDA accepts NDA for INSYS Therapeutics’ naloxone nasal spray to treat known or suspected opioid overdose
Image: FDA has accepted NDA for INSYS Therapeutics’ naloxone nasal spray to treat known or suspected opioid overdose. Photo: courtesy of flockine from Pixabay.